NCT05343143View on ClinicalTrials.gov

NeuraGen 3D Pilot Study

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 15, 2022

Primary Completion Date

July 11, 2023

Study Completion Date

May 13, 2024

Conditions
Digital Nerve Injury
Interventions
DEVICE

NeuraGen 3D Nerve Guide Matrix

Integra NeuraGen 3D Nerve Guide Matrix is a resorbable implant for the repair of peripheral nerve gaps.

Trial Locations (4)

10021

Hospital for Special Surgery, New York

15261

University of Pittsburgh Medical Center, Pittsburgh

27708

Duke University, Durham

43210

The Ohio State University Wexner Medical Center, Columbus

Sponsors
All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY

NCT05343143 - NeuraGen 3D Pilot Study | Biotech Hunter | Biotech Hunter